Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya

[1]  The immunological basis for immunization series Module , 2009 .

[2]  M. Ehlers,et al.  Prevalence of vaccine‐derived polioviruses in stools of immunodeficient children in South Africa , 2006, Journal of applied microbiology.

[3]  N. Halsey,et al.  Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[4]  M. Ehlers,et al.  Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. , 2006, Diagnostic microbiology and infectious disease.

[5]  M. Pallansch,et al.  Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. , 2005, The Journal of infectious diseases.

[6]  E. Bégaud,et al.  No evidence of prolonged enterovirus excretion in HIV‐seropositive patients , 2005, Tropical medicine & international health : TM & IH.

[7]  M. Iturriza-Gómara,et al.  An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. , 2004, AIDS.

[8]  M. Pallansch,et al.  Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses , 2004, Journal of Clinical Microbiology.

[9]  G. Wormser AIDS and other manifestations of HIV infection , 2004 .

[10]  Francis Delpeyroux,et al.  Circulating vaccine-derived polioviruses: current state of knowledge. , 2004, Bulletin of the World Health Organization.

[11]  M. Pallansch,et al.  Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. , 2003, The Journal of infectious diseases.

[12]  M. Pallansch,et al.  Serial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China , 2003, Journal of Virology.

[13]  M. Pallansch,et al.  Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  J. Buscombe,et al.  SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis. , 2003, The Journal of infection.

[15]  W. Moss,et al.  Immunization of children at risk of infection with human immunodeficiency virus. , 2003, Bulletin of the World Health Organization.

[16]  F. Dabis,et al.  HIV-1/AIDS and maternal and child health in Africa , 2002, The Lancet.

[17]  M. Pallansch,et al.  Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus , 2002, Science.

[18]  M. Pallansch,et al.  Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. , 2001, International journal of epidemiology.

[19]  Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[20]  From the Centers for Disease Control and Prevention. Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993. , 2001, JAMA.

[21]  J. A. Suárez,et al.  Enteric Virus Infections and Diarrhea in Healthy and Human Immunodeficiency Virus-Infected Children , 2000, Journal of Clinical Microbiology.

[22]  W. Dowdle,et al.  Stopping poliovirus vaccination after eradication: issues and challenges. , 2000, Bulletin of the World Health Organization.

[23]  M. Pallansch,et al.  Typing of Human Enteroviruses by Partial Sequencing of VP1 , 1999, Journal of Clinical Microbiology.

[24]  R. van Furth,et al.  Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report , 1999, BMJ.

[25]  M. Pallansch,et al.  Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient , 1998, Journal of Clinical Microbiology.

[26]  M. Pallansch,et al.  Serotype-Specific Identification of Polioviruses by PCR Using Primers Containing Mixed-Base or Deoxyinosine Residues at Positions of Codon Degeneracy , 1996, Journal of Clinical Microbiology.

[27]  Module The Immunological Basis for Immunization Series Module 6 : Poliomyelitis GLOBAL PROGRAMME FOR VACCINES AND IMMUNIZATION EXPANDED PROGRAMME ON IMMUNIZATION , 1998 .

[28]  M. Pallansch,et al.  Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. , 1997, The Journal of infectious diseases.

[29]  M. Pallansch,et al.  Comparative study of five methods for intratypic differentiation of polioviruses , 1995, Journal of clinical microbiology.

[30]  P. Strebel,et al.  Vaccine-associated paralytic poliomyelitis and HIV infection , 1994, The Lancet.

[31]  A. Rubino,et al.  Intestinal malabsorption of HIV‐infected children: relationship to diarrhoea, failure to thrive, enteric micro‐organisms and immune impairment The Italian Paediatric Intestinal/HIV Study Group* , 1993, AIDS.

[32]  I. Onorato,et al.  Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanuspertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 , 1993 .

[33]  I. Onorato,et al.  Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. , 1993, The Journal of pediatrics.

[34]  M. Mulders,et al.  Molecular epidemiology of polioviruses. , 1995, Reviews of infectious diseases.